Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Clinical and Molecular Allergy is Scopus-indexed (Q1, CiteScore 8.7). Published by BioMed Central Ltd.
Checked against the index lists dated .
ISSN 1476-7961Verify ISSN ↗
Publisher: BioMed Central Ltd
Cost to publish: About US$2,490 to publish open access (publisher list price, via OpenAlex) — subscription publishing may be free
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Immunology and Allergy | 47 / 234 | 80th | Q1 |
| Immunology | 53 / 243 | 78th | Q1 |
| Molecular Biology | 92 / 414 | 77th | Q1 |
Not listed in: Web of Science, DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2015–2024 (also 2003–2013), best quartile Q1, CiteScore 8.7.
Clinical and Molecular Allergy is Q1 in Immunology and Allergy (rank 47 of 234), Q1 in Immunology (rank 53 of 243) and Q1 in Molecular Biology (rank 92 of 414), by CiteScore 2025.
Clinical and Molecular Allergy is not in the Web of Science Core Collection (SCIE, SSCI, AHCI or ESCI), so Clarivate publishes no Journal Impact Factor for it. Its Scopus CiteScore is 8.7, quartile Q1, 80th percentile. Any "impact factor" quoted elsewhere is not the Clarivate metric. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.685, quartile Q3, with an H-index of 46.
The publisher lists an article processing charge of about US$2,490 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Clinical and Molecular Allergy is published by BioMed Central Ltd. Its ISSN is 1476-7961.
No — it is not currently in the Web of Science core collections (SCIE, SSCI, AHCI or ESCI).
No — it is not registered as an open-access journal in DOAJ or Scopus.
Clinical and Molecular Allergy has an h-index of 52 and a 2-year mean of 0 citations per paper (OpenAlex). Its Scopus CiteScore is 8.7, quartile Q1. On 2-year citations it ranks #217 of 231 Scopus journals in Immunology and Allergy.
Clinical and Molecular Allergy published 1 papers in 2024; its busiest recent year was 2015 with 31. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 50 research articles (2021–2023), authors are most often from Italy (40%), Iran (16%) and Sri Lanka (5%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.